HighTower Advisors
OMIC

HighTower Advisors’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

HighTower Advisors’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,607
Closed -$342K – 4115
2024
Q4 		$342K Hold
17,607
– – ﹤0.01% 2782
2024
Q3 		$276K Hold
17,607
– – ﹤0.01% 2872
2024
Q2 		$150K Sell
17,607
-4
-0% -$47 ﹤0.01% 3112
2024
Q1 		$272K Buy
17,611
+3,667
+26% +$55.9K ﹤0.01% 2757
2023
Q4 		$193K Buy
13,944
+5,000
+56% +$59.1K ﹤0.01% 3022
2023
Q3 		$103K Hold
8,944
– – ﹤0.01% 3100
2023
Q2 		$221K Buy
8,944
+1,000
+13% +$29.3K ﹤0.01% 2791
2023
Q1 		$288K Buy
7,944
+1,330
+20% +$81.5K ﹤0.01% 2483
2022
Q4 		$398K Sell
6,614
-337
-5% -$22.6K ﹤0.01% 2282
2022
Q3 		$521K Buy
6,951
+1,667
+32% +$174K ﹤0.01% 1998
2022
Q2 		$606K Hold
5,284
– – ﹤0.01% 1928
2022
Q1 		$1M Buy
5,284
+337
+7% +$78K ﹤0.01% 1760
2021
Q4 		$1.72M Buy
+4,947
New +$1.92M ﹤0.01% 1450

HighTower Advisors's OMIC Position: Q1 2025 in Review

HighTower Advisors sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2025, closing a stake of 17,607 shares — an estimated $342K sold.

HighTower Advisors first reported a position in OMIC in Q4 2021 and held it in 13 quarters. The position peaked at $1.72M in Q4 2021. 0 funds tracked by Wall St. Rank hold OMIC as of Q1 2025.

  • HighTower Advisors reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • HighTower Advisors sold 17,607 Singular Genomics Systems, Inc. Common Stock shares in Q1 2025, an estimated $342K.
  • HighTower Advisors first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 13 quarters.
  • HighTower Advisors's Singular Genomics Systems, Inc. Common Stock position peaked at $1.72M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.